Immunotherapeutic potential of whole tumour cells Stephen WardDavid CaseyStephen Todryk Position Paper 14 June 2002 Pages: 351 - 357
Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin Lei YaoSandra E. PikeGiovanna Tosato Original Article 03 July 2002 Pages: 358 - 366
Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells P. JantscheffG. SpagnoliC. Rochlitz Original Article 25 June 2002 Pages: 367 - 375
Protein A-induced apoptosis of cancer cells is effected by soluble immune mediators Tanya DasGaurisankar SaPrasanta K. Ray Original Article 19 June 2002 Pages: 376 - 380
Suppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8 cells by soluble TGF-β receptor type II Wenli ZhaoMasonobu KobayashiMasuo Hosokawa Original Article 25 June 2002 Pages: 381 - 388
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21 Isabel MalenoMiguel López-NevotFederico Garrido Original Article 28 June 2002 Pages: 389 - 396
14th Pezcoller Symposium: The Novel Dichotomy of Immune Interactions with Tumors 30 May–1 June 2002, Trento, Italy Syposium Series 28 June 2002 Pages: 397 - 408